Amoo-Gottfried is a seasoned marketing leader with decades of experience helping global transformative brands change how consumers think about their everyday lives. He served as Chief Marketing Officer at DoorDash and in leadership roles at Meta, where he shaped narratives that made the brands category leaders and set the standard for captivating storytelling on an international scale. He has deep experience at some of the world’s top marketing agencies, including Leo Burnett, Wieden + Kennedy, and Publicis, where he established the company’s first owned agency in Central & West Africa. Amoo-Gottfried also serves on the board of beloved consumer companies, including StitchFix and Vital Farms.
“Kofi has a wealth of experience in building and growing brands that change what people believe is possible in everything from home delivery to human connection,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “At Hims & Hers, we’re transforming the everyday health experience by making it simple, deeply personal, and built for real life. Consumers deserve better from their healthcare and, as we continue working to help millions of people around the world feel great, we believe Kofi is an incredibly valuable nominee to join our board.”
“I believe Hims & Hers is on track to be the next company that becomes a daily companion to people everywhere,” said Kofi Amoo-Gottfried. “The company’s focus on making healthcare not only simple, but a completely reimagined experience, is shifting the entire industry, and I’m honored to be nominated as they begin this next chapter of growth.”
In addition to Amoo-Gottfried, Hims & Hers also nominates the following returning members:
Additionally, the Company and the Board are grateful to Christiane Pendarvis and Dr. Pat Carroll for their many years of dedicated service. Ms. Pendarvis and Dr. Carroll are not up for re-election at the 2026 annual meeting, and the total size of the board will be decreased to 9, effective as of the election of directors at the annual meeting. Dr. Carroll will continue to serve as the company’s Global Chief Medical Officer.
Cautionary Note Regarding Forward-Looking Statements
This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “anticipates,” “expects,” “intends,” “plans,” “decides,” “may,” “will,” “likely,” “potential,” “future,” “coming,” “starting,” “hope,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding the board of directors and the company’s future growth. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the results of the shareholder vote at the 2026 annual meeting; changes or developments in the composition of the board of directors; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this communication are made only as of April 28, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
